Peptides by condition · Muscles, bones, joints and skin

Peptides studied for skin wounds and ulcers

Checked against our study pages and the FDA labelsPublished by PepVault

Our library holds 10 study pages on skin wounds and ulcers: 5 in people (all meta-analyses or randomized trials), and 5 in animals. They studied 6 compounds, with this many study pages each: LL-37 2, HGH 1, TB-500 2, GHK-Cu 3, BPC-157 1 and Thymosin Beta-4 1.

What the research on skin wounds and ulcers looks like

Wounds that are slow to close are a common problem with diabetes, poor circulation and old age; diabetic foot ulcers and venous leg ulcers are the main types. The peptides studied for wound healing were mostly put on the skin as a gel or cream, and the work spans small trials in people and wound models in mice and rats.

Wound studies in people measure how much of the wound has closed, how many wounds closed fully, and the healthy new tissue that fills the base, called granulation. Animal studies time how fast a cut or burn closes and look at collagen under a microscope.

Ulcers in people have causes, such as poor blood flow, that a wound cut in a healthy animal does not have. Look for a placebo or standard-care comparison, since many ulcers close with good wound care alone.

Our study pages on skin wounds and ulcers by design: Trials in people 5, Other in people 0, Animals 5, Cells 0, of 10.Trials in people5Other in people0Animals5Cells0
How many of the 10 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.
A smiling man in a grey training top on a sofa with a foam roller beside him, his phone in his hands

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The 10 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

  1. LL-37

    2 in people

    For skin wounds and ulcers, 2 of our study pages are filed under LL-37: 2 randomized trials in people. The largest in people enrolled 148 people and was published in 2021. They were published from 2021 to 2023, in Wound Repair Regen and Arch Dermatol Res.

    LL-37 has no FDA-approved product: Drugs@FDA lists no application for it.

  2. HGH

    1 in people

    For skin wounds and ulcers, 1 of our study pages is filed under HGH: 1 meta-analysis in people. It pooled 701 people and was published in 2014, in Cochrane Database Syst Rev.

    FDA-approved for other uses, not for skin wounds and ulcers: Humatrope (injection) for growth failure in children who make too little growth hormone and several other causes of short stature, and growth hormone deficiency in adults.

  3. TB-500

    1 in people · 1 in animals

    For skin wounds and ulcers, 2 of our study pages are filed under TB-500: 1 randomized trial in people, and 1 animal study (mice). The largest in people enrolled 73 people and was published in 2010. They were published from 2003 to 2010, in Ann N Y Acad Sci and Wound Repair Regen.

    TB-500 has no FDA-approved product: Drugs@FDA lists no application for it or for thymosin beta-4.

  4. GHK-Cu

    1 in people · 2 in animals

    For skin wounds and ulcers, 3 of our study pages are filed under GHK-Cu: 1 randomized trial in people, and 2 animal studies (mice and rats). Its study in people does not give their size on our pages. They were published from 1993 to 2017, in Wound Repair Regen and J Clin Invest.

    GHK-Cu has no FDA-approved drug: Drugs@FDA lists no application for it.

  5. BPC-157

    1 in animals

    For skin wounds and ulcers, 1 of our study pages is filed under BPC-157: 1 animal study (rats). It was published in 2015, in Drug Des Devel Ther.

    BPC-157 has no FDA-approved product: Drugs@FDA lists no application for it.

  6. Thymosin Beta-4

    1 in animals

    For skin wounds and ulcers, 1 of our study pages is filed under Thymosin Beta-4: 1 animal study (rats). It was published in 1999, in J Invest Dermatol.

    Thymosin beta-4 has no FDA-approved product: Drugs@FDA lists no application for it.

Side by side

For the 6 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

CompoundIn peopleAnimals or cellsLargest in peopleFDA
LL-3720148Not approved
HGH10701Approved for other uses
TB-5001173Not approved
GHK-Cu12—Not approved
BPC-15701—Not approved
Thymosin Beta-401—Not approved

What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

Questions

Which peptides have been studied for skin wounds and ulcers?

Our 10 study pages on skin wounds and ulcers are filed under 6 compounds, with this many each: LL-37 2, HGH 1, TB-500 2, GHK-Cu 3, BPC-157 1 and Thymosin Beta-4 1. GHK-Cu has the most.

Have any been tested in people with skin wounds and ulcers?

Yes: 5 of the 10 were in people, all of them meta-analyses or randomized trials (LL-37, HGH, TB-500 and GHK-Cu). The largest pooled 701 people: “HGH: adult burn wounds healed 9.07 days faster in a meta-analysis” (2014).

Is any peptide FDA-approved for skin wounds and ulcers?

Not by the labels our status pages read: of the 6 compounds here with an FDA record, none has a use tied to skin wounds and ulcers. HGH is FDA-approved for other uses.

How large were the studies in people on skin wounds and ulcers?

Of the 5 in people, 3 give their size on our pages: 2 had 100 to 999 and 1 had fewer than 100. The largest, a meta-analysis from 2014, pooled 701.

What did the animal and cell studies on skin wounds and ulcers use?

5 animal studies (mice and rats), filed under GHK-Cu, BPC-157, TB-500 and Thymosin Beta-4. A result in animals or cells shows what to test next, not what happens in a person.

What is the newest study on skin wounds and ulcers here?

Of our study pages on skin wounds and ulcers, the newest is “LL-37 cream: bigger granulation gains in diabetic foot ulcers”, a randomized trial in people published in 2023.

How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

Track it in the app

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo